HIV Citation List: September 2, 2011 - September 15, 2011

Pubmed citations

1. Synthesis of Quinolin-2-one Alkaloid Derivatives and Their Inhibitory Activities against HIV-1 Reverse Transcriptase. Cheng, P., Q. Gu, W. Liu, J.F. Zou, Y.Y. Ou, Z.Y. Luo, and J.G. Zeng, Molecules, 2011. 16(9): p. 7649-7661; PMID[21900867].

[Pubmed]. HIV_0902-091511.

2. Selection of a Synthetic Glycan Oligomer from a Library of DNA-templated Fragments against DC-SIGN and Inhibition of HIV gp120 Binding to Dendritic Cells. Ciobanu, M., K.T. Huang, J.P. Daguer, S. Barluenga, O. Chaloin, E. Schaeffer, C.G. Mueller, D.A. Mitchell, and N. Winssinger, Chemical Communications (Cambridge, England), 2011. 47(33): p. 9321-9323; PMID[21785785].

[Pubmed]. HIV_0902-091511.

3. P1-Substituted Symmetry-Based Human Immunodeficiency Virus Protease Inhibitors with Potent Antiviral Activity against Drug-Resistant Viruses. Degoey, D.A., D. Grampovnik, H.J. Chen, W. Flosi, L. Klein, T. Dekhtyar, V. Stoll, M. Mamo, A. Molla, and D. Kempf, Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21899332].

[Pubmed]. HIV_0902-091511.

4. TMC310911, a Novel Human Immunodeficiency Virus Type-1 Protease Inhibitor shows in Vitro an Improved Resistance Profile and Higher Genetic Barrier to Resistance Compared with Current Protease Inhibitors. Dierynck, I., H. Van Marck, M. Van Ginderen, T.H. Jonckers, M.N. Nalam, C.A. Schiffer, A. Raoof, G. Kraus, and G. Picchio, Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21896904].

[Pubmed]. HIV_0902-091511.

5. Susceptibility of HIV-2 Primary Isolates to CCR5 and CXCR4 Monoclonal Antibodies, Ligands and Small Molecule Inhibitors. Espirito-Santo, M., Q. Santos-Costa, M. Calado, P. Dorr, and J.M. Azevedo Pereira, AIDS Research and Human Retroviruses, 2011. [Epub ahead of print]; PMID[21902586].

[Pubmed]. HIV_0902-091511.

6. Synergistic Activity Profile of Griffithsin in Combination with Tenofovir, Maraviroc and Enfuvirtide against HIV-1 Clade C. Ferir, G., K.E. Palmer, and D. Schols, Virology, 2011. 417(2): p. 253-258; PMID[21802104].

[Pubmed]. HIV_0902-091511.

7. Inhibition of HIV-1 by Octadecyloxyethyl Esters of (S)-[3- Hydroxy-2-(phosphonomethoxy)propyl] Nucleosides and Evaluation of Their Mechanism of Action. Magee, W.C., N. Valiaeva, J.R. Beadle, D.D. Richman, K.Y. Hostetler, and D.H. Evans, Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21896914].

[Pubmed]. HIV_0902-091511.

8. In Vitro Antiviral Activities of Extracts Derived from Daucus maritimus Seeds. Miladi, S., N. Abid, C. Debarnot, M. Damak, B. Canard, M. Aouni, and B. Selmi, National Product Research, 2011. [Epub ahead of print]; PMID[21895456].

[Pubmed]. HIV_0902-091511.

9. Biophysical Investigations of GBV-C E1 Peptides as Potential Inhibitors of HIV-1 Fusion Peptide. Sanchez-Martin, M.J., P. Urban, M. Pujol, I. Haro, M.A. Alsina, and M.A. Busquets, Chemphyschem, 2011. [Epub ahead of print]; PMID[21905195].

[Pubmed]. HIV_0902-091511.

10. Development of Dual-Acting Pyrimidinediones as Novel and Highly Potent Topical Anti-HIV Microbicides. Watson-Buckheit, K., L. Yang, and R.W. Buckheit, Jr., Antimicrobial Agents and Chemotherapy, 2011. [Epub ahead of print]; PMID[21896906].

[Pubmed]. HIV_0902-091511.

ISI Web of Knowledge citations:

11. Synthesis and Anti-HIV Activity of Novel 3-substituted phenyl-6,7-dimethoxy-3a,4-dihydro-3h-indeno[1,2-c]isoxazole Analogues. Ali, M.A., R. Ismail, T.S. Choon, Y.K. Yoon, A.C. Wei, S. Pandian, J.G. Samy, E. De Clercq, and C. Pannecouque, Acta Poloniae Pharmaceutica, 2011. 68(3): p. 343-348; ISI[000294185500005].

[WOS]. HIV_0902-091511.

12. Cell-Free HIV-1 Virucidal Action by Modified Peptide Triazole Inhibitors of Env gp120. Bastian, A.R., Kantharaju, K. McFadden, C. Duffy, S. Rajagopal, M.R. Contarino, E. Papazoglou, and I. Chaiken, ChemMedChem, 2011. 6(8): p. 1335-1339; ISI[000294112900001].

[WOS]. HIV_0902-091511.

13. Hydrogen Bonds of Anti-Hiv Active Aminophenols. Belkov, M.V., G.A. Ksendzova, I.V. Skornyakov, V.L. Sorokin, G.B. Tolstorozhev, and O.I. Shadyro, Journal of Applied Spectroscopy, 2011. 78(2): p. 197-202; ISI[000294010600007].

[WOS]. HIV_0902-091511.

14. High-Functional-Avidity Cytotoxic T Lymphocyte Responses to HLA-B-Restricted Gag-Derived Epitopes Associated with Relative HIV Control. Berger, C.T., N. Frahm, D.A. Price, B. Mothe, M. Ghebremichael, K.L. Hartman, L.M. Henry, J.M. Brenchley, L.E. Ruff, V. Venturi, F. Pereyra, J. Sidney, A. Sette, D.C. Douek, B.D. Walker, D.E. Kaufmann, and C. Brander, Journal of Virology, 2011. 85(18): p. 9334-9345; ISI[000293956400008].

[WOS]. HIV_0902-091511.

15. Inhibition on HIV-1 Integrase Activity and Nitric Oxide Production of Compounds from Ficus glomerata. Bunluepuech, K., T. Sudsai, C. Wattanapiromsakul, and S. Tewtrakul, Natural Product Communications, 2011. 6(8): p. 1095-1098; ISI[000294035300011].

[WOS]. HIV_0902-091511.

16. Inhibition of HIV-1 Integration in Ex Vivo-Infected CD4 T Cells from Elite Controllers. Buzon, M.J., K. Seiss, R. Weiss, A.L. Brass, E.S. Rosenberg, F. Pereyra, X.G. Yu, and M. Lichterfeld, Journal of Virology, 2011. 85(18): p. 9646-9650; ISI[000293956400038].

[WOS]. HIV_0902-091511.

17. New bis(Thiosemicarbazonate) Gold(III) Complexes Inhibit HIV Replication at Cytostatic Concentrations: Potential for Incorporation into Virostatic Cocktails. Fonteh, P.N., F.K. Keter, and D. Meyer, Journal of Inorganic Biochemistry, 2011. 105(9): p. 1173-1180; ISI[000294085500008].

[WOS]. HIV_0902-091511.

18. Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2. Friedman, J., W.K. Cho, C.K. Chu, K.S. Keedy, N.M. Archin, D.M. Margolis, and J. Karn, Journal of Virology, 2011. 85(17): p. 9078-9089; ISI[000293626100057].

[WOS]. HIV_0902-091511.

19. Structure and Conformational Analysis of the Anti-HIV AZT 5 '-Aminocarbonylphosphonate Prodrug using DFT Methods. Molina, A.T. and M.A. Palafox, Chemical Physics, 2011. 387(1-3): p. 11-24; ISI[000294108600003].

[WOS]. HIV_0902-091511.

20. Synthesis and Chromatographic Enantioresolution of Anti-HIV Quinolone Derivatives. Natalini, B., R. Sardella, S. Massari, F. Ianni, O. Tabarrini, and V. Cecchetti, Talanta, 2011. 85(3): p. 1392-1397; ISI[000294092800027].

[WOS]. HIV_0902-091511.

21. An Optimized MM/PBSA Virtual Screening Approach Applied on an HIV-1 gp41 Fusion Peptide Inhibitor. Venken, T., D. Krnavek, J. Munch, F. Kirchhoff, P. Henklein, M. De Maeyer, and A. Voet, European Biophysics Journal with Biophysics Letters, 2011. 40: p. 120-120; ISI[000293637300285].

[WOS]. HIV_0902-091511.

22. Structure Based Discovery and Optimization of First-in-class Inhibitors of the HIV-1 IN-LEDGF/p75 Interaction. Voet, A.R.D., F. Christ, A. Marchand, P. Chaltin, S. Nicolet, S. Strelkov, Z. Debyser, and M. De Maeyer, European Biophysics Journal with Biophysics Letters, 2011. 40: p. 120-121; ISI[000293637300286].

[WOS]. HIV_0902-091511.